LPATH
Lpath, Inc. is the category leader in the discovery and development of monoclonal antibodies that target (neutralize) bioactive lipids. The study of lipids (called lipidomics) is an emerging field of research that has already identified dozens of bioactive lipids that contribute to disease, with the promise of hundreds more as funding in the area continues to accelerate. Once a disease-causing lipid is identified, however, the challenge becomes one of generating a compound that neutralizes the relevant bioactive lipid. With its ImmuneY2:tm: platform technology and robust patent estate, Lpath is uniquely positioned to meet such challenges and exploit these opportunities.
LPATH
Industry:
Biopharma Biotechnology Medical Device
Founded:
2006-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.lpath.com
Total Employee:
11+
Status:
Active
Contact:
858-678-0800
Email Addresses:
[email protected]
Total Funding:
29.91 M USD
Technology used in webpage:
LiteSpeed CPanel Smart App Banner Google No Translate Namecheap DNS Namecheap Hosting Google Plus Embedded Posts
Similar Organizations
Capella BioScience
Capella Bioscience engages in the discovery and development of monoclonal antibodies.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Founder
Stock Details
Official Site Inspections
http://www.lpath.com
- Host name: ec2-18-119-154-66.us-east-2.compute.amazonaws.com
- IP address: 18.119.154.66
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "LPATH"
LPATH - Crunchbase Company Profile & Funding
Lpath, Inc. is the category leader in the discovery and development of monoclonal antibodies that target (neutralize) bioactive lipids. The study of lipids (called lipidomics) is an emerging field of …See details»
Lpath Company Profile 2024: Valuation, Investors, Acquisition
Lpath was founded in 1997. Where is Lpath headquartered? Lpath is headquartered in San Diego, CA. What is the size of Lpath? Lpath has 20 total employees. What industry is Lpath …See details»
Lpath Inc. - San Diego, USA - bionity.com
Lpath, Inc., headquartered in San Diego, California, is the category leader in lipidomics-based therapeutics, an emerging field of medical science whereby bioactive signaling lipids are …See details»
Lpath, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Lpath, Inc. with its drug pipeline, therapeutic area, technology platform, 6 clinical trials, 1 news, and 27 literature, Drug:Sonepcizumab, Lpathomab.See details»
Lpath - Products, Competitors, Financials, Employees, …
Lpath (NASDAQ: LPTN) discovers and develops therapeutic antibodies that bind and inhibit bioactive lipids that contribute to disease. Use the CB Insights Platform to explore Lpath's full …See details»
LPATH THERAPEUTICS INC. - LinkedIn
Lpath, Inc. is focused on bioactive signaling lipids as targets for treating and diagnosing important human diseases, including age-related macular degeneration, cancer, and CNS disease ...See details»
Apollo Endosurgery and Lpath Sign Merger Agreement - Athyrium
Sep 8, 2016 executive officers of Lpath is also included in Lpath Annual Report on Form 10-K for the year ended December 31, 2015 and the proxy statement for Lpath's 2016 Annual Meeting …See details»
LPATH - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Oct 7, 2014: Post-IPO Equity - …See details»
LPATH - Contacts, Employees, Board Members, Advisors & Alumni …
Lpat focuses on the discovery and development of monoclonal antibodies that target bioactive lipids.See details»
Lpath, Inc. - VentureRadar
Dec 31, 2014 Similar Companies: Avalanche Biotechnologies USA Publicly Traded Founded in 2006, Avalanche Biotechnologies, Inc., is a privately held, clinical-stage biotechnology …See details»
Lpath, Inc. Creates First Neutralizing Monoclonal Antibodies
Jul 17, 2006 Lpath’s success with LPA validates the ability of its technology and its research team to produce antibodies for these therapeutically important, yet highly challenging, targets.” …See details»
Lpath, Inc. Submits Investigational New Drug Application For
Feb 2, 2015 Lpath plans to begin enrolling patients once the FDA’s IND review period is complete and the study has been approved by the trial sites’ investigational review boards. …See details»
Lpath, Inc. | Insights
Jan 24, 2017 Lpath Therapeutics Inc. Neighborhood Connections, Inc. See more in Biomedtracker. Latest on Lpath, Inc. Already A Biomedtracker Subscriber? You have access …See details»
LPATH - Crunchbase
Lpat focuses on the discovery and development of monoclonal antibodies that target bioactive lipids.See details»
New Published Paper Shows Efficacy of Lpath's Anti-LPA Antibody ...
Mar 5, 2014 Lpath, Inc. (NASDAQ: LPTN ), the industry leader in bioactive lipid-targeted therapeutics, has brought scientists one step closer to finding a potential treatment for …See details»
Lpath Initiates Dosing of iSONEP in First of Two Proof ... - Pfizer
Sep 9, 2011 Lpath, Inc. (OTCBB: LPTN), the industry leader in lipidomics-based antibody therapeutics, has initiated dosing in its PEDigree clinical trial where iSONEP(TM) is being …See details»
Lpath's Anti-LPA Antibody, Lpathomab ... - Technology Networks
Jun 3, 2011 Lpath utilized ImmuneY2 to discover and advance iSONEP™, which will soon be in two Phase 2-level wet-AMD clinical trials, and ASONEP™, which will be further investigated in …See details»
LPATH - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Nov 24, 2024 LPATH uses 6 technology products and services including HTML5, Wordpress, and GoDaddy Premium DNS, according to G2 Stack. LPATH is actively using 7 technologies …See details»
Lpathomab - AdisInsight - Springer
Lpath was developing Lpathomab, a monoclonal antibody directed at the bioactive lipid lysophosphatidic acid (LPA), for the treatment of brain and spinal cord ... If your organization …See details»
LPath Inc. A Small Biotechnology Company With Big Potential
Jan 11, 2014 LPath's fill/finish contractor was not in compliance with the FDA's Good Manufacturing Practice Requirements and as such the FDA put a clinical hold on LPath until …See details»